BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36724402)

  • 21. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of state cancer registry treatment information for adolescent and young adult women.
    Anderson C; Baggett CD; Rao C; Moy L; Kushi LH; Chao CR; Nichols HB
    Cancer Epidemiol; 2020 Feb; 64():101652. PubMed ID: 31811983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons.
    Lee-Feldstein A; Feldstein PJ; Buchmueller T; Katterhagen G
    J Gen Intern Med; 2001 Mar; 16(3):189-99. PubMed ID: 11318915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use and timeliness of radiation therapy after breast-conserving surgery in low-income women with early-stage breast cancer.
    Wheeler SB; Wu Y; Meyer AM; Carpenter WR; Richardson LC; Smith JL; Lewis MA; Weiner BJ
    Cancer Invest; 2012 May; 30(4):258-67. PubMed ID: 22489864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of breast conserving surgery: linking insurance claims with tumor registry data.
    Maskarinec G; Dhakal S; Yamashiro G; Issell BF
    BMC Cancer; 2002; 2():3. PubMed ID: 11879527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Completeness of American Cancer Registry Treatment Data: implications for quality of care research.
    Mallin K; Palis BE; Watroba N; Stewart AK; Walczak D; Singer J; Barron J; Blumenthal W; Haydu G; Edge SB
    J Am Coll Surg; 2013 Mar; 216(3):428-37. PubMed ID: 23357724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inferior Clinical Outcomes for Patients with Medicaid Insurance After Surgery for Degenerative Lumbar Spondylolisthesis: A Prospective Registry Analysis of 608 Patients.
    Chan AK; Letchuman V; Mummaneni PV; Burke JF; Agarwal N; Bisson EF; Bydon M; Foley KT; Shaffrey CI; Glassman SD; Wang MY; Park P; Potts EA; Shaffrey ME; Coric D; Knightly JJ; Fu KM; Slotkin JR; Asher AL; Virk MS; Kerezoudis P; Alvi MA; Guan J; Haid RW; DiGiorgio A
    World Neurosurg; 2022 Aug; 164():e1024-e1033. PubMed ID: 35636667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy.
    Young WW; Marks SM; Kohler SA; Hsu AY
    Med Care; 1996 Oct; 34(10):1003-17. PubMed ID: 8843927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of primary payer in cancer registry and discharge data.
    Kwon Y; Perraillon MC; Drake C; Jacobs BL; Bradley CJ; Sabik LM
    Am J Manag Care; 2023 Sep; 29(9):455-462. PubMed ID: 37729528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Influencing Receipt of Interventional Pain Management Among Medicaid Beneficiaries with Cancer.
    Halpern MT; Fiero MH
    Pain Physician; 2019 May; 22(3):E147-E155. PubMed ID: 31151338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
    Wu VS; Khlopin M; Jagsi R; McClelland S
    Pract Radiat Oncol; 2024; 14(1):24-27. PubMed ID: 37748680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishing screening from diagnostic mammograms using Medicare claims data.
    Fenton JJ; Zhu W; Balch S; Smith-Bindman R; Fishman P; Hubbard RA
    Med Care; 2014 Jul; 52(7):e44-51. PubMed ID: 22922433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance mammography for Medicaid/Medicare breast cancer patients.
    Carcaise-Edinboro P; Bradley CJ; Dahman B
    J Cancer Surviv; 2010 Mar; 4(1):59-66. PubMed ID: 20091247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care factors related to stage at diagnosis and survival among Medicare patients with colorectal cancer.
    Lee-Feldstein A; Feldstein PJ; Buchmueller T
    Med Care; 2002 May; 40(5):362-74. PubMed ID: 11961471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data.
    Pace LE; Ayanian JZ; Wolf RE; Knowlton R; Gershman ST; Hawkins SS; Keating NL
    Cancer Med; 2022 Jul; 11(13):2679-2686. PubMed ID: 35312162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status.
    Churilla TM; Egleston B; Bleicher R; Dong Y; Meyer J; Anderson P
    Breast J; 2017 Mar; 23(2):169-176. PubMed ID: 27797159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population.
    Koroukian SM; Cooper GS; Rimm AA
    Health Serv Res; 2003 Jun; 38(3):947-60. PubMed ID: 12822920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.